In vivo dilatation of the ductus arteriosus by rho kinase inhibition in the rat

Neonatology

Volumn 95, Issue 4, 2009, Pages 324-331

  Momma, Kazuo ^a   Toyoshima, Katsuaki ^a,b   Sun, Fang ^a   Nakanishi, Toshio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

Ductus arteriosus; Fasudil; Fetus; Neonate; Neonatology; Patent ductus arteriosus; Rho kinase inhibitor

Indexed keywords

FASUDIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DUCTUS ARTERIOSUS; DUCTUS ARTERIOSUS OBLITERATION; FEMALE; FETUS; GESTATIONAL AGE; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; THERAPY DELAY;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; ANIMALS, NEWBORN; CARDIOVASCULAR SURGICAL PROCEDURES; DOSE-RESPONSE RELATIONSHIP, DRUG; DUCTUS ARTERIOSUS; FEMALE; MALE; MODELS, ANIMAL; PREGNANCY; RATS; RATS, WISTAR; RESPIRATORY INSUFFICIENCY; RHO-ASSOCIATED KINASES; VASODILATION; VASODILATOR AGENTS;

RATTUS;

EID: 57349172009     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000181162     Document Type: Article

References (26)

1. Rudolph AM: Congenital Diseases of the Heart, ed 2, revised. Armonk, Futura, 2001, pp 155-196.
2. Moor P, Brook MM, Heymann MA: Patent ductus arteriosus; in Allen HD, Gutgesell HP, Clark EB, Driscoll DJ (eds): Moss Adams Heart Disease in Infants, Children, and Adolescents, ed 6, revised. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 652-669.
3. Clyman RI: Mechanisms regulating the ductus arteriosus. Biol Neonate 2006; 89: 330 - 335.
4. Corbert AJ: Medical manipulation of the ductus arteriosus; in Garson A Jr, Bricker J T, Fisher DJ, Neish SR (eds): The Science and Practice of Pediatric Cardiology, ed 2, revised. Baltimore, Williams & Wilkins, 1998, pp 2489-2513.
5. Momma K, Takao A, Sone K, Tashiro M: Prostaglandin E1 treatment of ductus-de-pendent infants with congenital heart disease. Int Angiol 1984; 3(suppl):33-38.
6. Kajimoto H, Hashimoto K, Bonnet SN, Haromy A, Harry G, Moudgil R, Nakanishi T, Rebeyka I, Thebaud B, Michelakis ED, Archer SL: Oxygen activates the rho/rho-kinase pathway and induces rhoB and Rock-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species. Circulation 2007; 15: 1777-1788.
7. Hong Z, Hong F, Olschewsli A, Cabrera JA, Varghese A, Nelson DP, Weir EK: Role of store-operated calcium channel and calcium sensitization in normoxic contraction of the ductus arteriosus. Circulation 2006; 114: 1372-1379.
8. Ito K, Shimomura E, Iwanaga T, Shiraishi M, Shindo K, Nakamura J, Nagumo H, Seto M, Sasaki Y, Takuwa Y: Essential role of rho kinase in the Ca sensitization of prostaglandin F2α-induced contraction of rabbit aortae. J Physiol 2003; 546: 823-836.
9. Wettschureck N, Offermanns S: Rho/Rhokinase mediated signaling in physiology and pathophysiology. J Mol Med 2002; 80:629-638.
10. Loirand G, Guerin P, Pacaud P: Rho kinase in cardiovascular physiology and pathophysiology. Circ Res 2006 ;98: 322-334.
11. Nagumo H, Sasaki Y, Ono Y, Okamoto H Seto M, Takuwa Y: Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol 2000; 278:C57-C65.
12. Costa M, Barogi S, Socci ND, Angeloni D, Maffei M, Baragatti B, Chiellini C, Grosso F, Coceani F: Gene expression in ductus arteriosus and aorta: comparison of birth and oxygen effect. Physiol Genom 2006; 25:256-262.
13. Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H, Katagiri T, Yamauchio K, Yui Y, Minamino T, Nakashima M, Kato K: Anti-anginal effect of fasudil, a rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovascul Pharmacol 2002; 40: 751-761.
14. Chrissobilis, S, Sobey CG: Evidence that rhokinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension. Circ Res-2001; 88: 774- 779.
15. Sato M, Tani E, Fujikawa H, Kaibuchi K: Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 2000; 87:195-200.
16. Momma K, Takao A: In vivo constriction of the ductus arteriosus by nonsteroidal antiinflammatory drugs in near-term and pre-term fetal rats. Pediatr Res 1987; 22: 567- 572.
17. Momma K, Uemura S, Nishihara S, Ota Y: Dilatation of the ductus arteriosus by pros-taglandins and prostaglandins' precursors. Pediatr Res 1980; 14: 1074 -1077.
18. Momma K, Takeuchi H: Constriction of fetal ductus arteriosus by nonsteroidal anti-inflammatory drugs. Prostaglandins 1983; 26: 631-643.
19. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods used in circulation research. Circ Res 1980;47: 1-9.
20. Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Takayasu M, Hidaka H: Mechanism of action of a nobel antivasospasm drug, HA1077. J Pharmacol Experim Therap 1987; 241:1033-1040.
21. Takakura K, Sugita K, Kikuti H, Saito I, Shibuya M, Suzuki Y, Sasaki T, Takemae N, Nagata I: Effect of AT-877 (Fasudil hydrochloride) on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoidal hemorrhage: Results of a prospective placebo-controlled doubleblind trial (in Japanese). Jpn Pharmacol Ther 1992; 20 (s uppl) :1627-1657.
22. Takakura K, Sugita K, Kikuti H, Saito I, Shibuya M, Suzuki Y, Sasaki T, Takemae N, Nagata I, Nakajima M: Clinical evaluation of AT-877 (Fasudil hydrochloride) on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoidal hemorrhage (in Japanese). Jpn Pharmacol Ther 1992; 20(suppl):1659-1676.
23. Mohri M, Shimokawa H, Hirakawa Y, MasumotoA, Takeshita A: Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 2003; 41: 15-19.
24. Satoh S, Utsunomiya T, Tsurui K, Kobayashi T, Ikegaki I, Sasaki Y, Asano T: Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life Sci 2001; 60: 1441-1453.
25. Asahikasei: Fasudil hydrochloride hydrate; in Japan Pharmaceutical Information Center (ed): Drugs in Japan. Ethical Drugs, ed 28 (in Japanese). Tokyo, Jiho, 2005, pp 1803- 1804.
26. Yokoyama U, Minamizawa T, Quan H, Ghatak S, Akaike T, Segi-Nishida E, Iwasaki S, Iwamoto M, Misra S, Tamura K, Hori H, Yokota S, Toole BT, Sugimoto Y, Ishikawa Y: Chronic activation of prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest 2006; 116: 3026-3034.